Gelesis
Ms. Bauerlein brings extensive experience in SEC reporting, Sarbanes-Oxley compliance, investor communications, strategic planning, business development, and corporate governance in high-growth direct-to-consumer, insurance rentals, and business-to-business revenue-generating companies.
She co-founded Inogen (NASDAQ: INGN), a global medical technology company offering innovative respiratory products for use in the homecare setting, and led it from start-up through initial public offering and commercialization with $300M+ in annual revenue.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Gelesis
Gelesis is developing biomimetic superabsorbent hydrogel therapies for obesity and other chronic metabolic diseases.